Promoter hypermethylation refers to the addition of methyl groups to the cytosine bases within the CpG islands of a gene's promoter region. This epigenetic alteration typically leads to gene silencing by preventing the binding of transcription factors, thereby inhibiting gene expression. In the context of cancer, promoter hypermethylation can play a crucial role in the inactivation of tumor suppressor genes.
